CREJUV BIO is a biopharmaceutical R&D company for the B2B tech licensing.
We license out technologies, not products, for the Aesthetic Botulinum Toxin.
It comes with ready-to-use liquid form in pre-filled syringe.
We will provide an optimized and patented botulinum toxin formulation for aesthetic treatment.
We were approved for the Start-Up Visa Program from Government of Canada in 2019 and founded the company in BC Canada in April 2020.
11Built CREJUV Team
04Applied Canada Start-Up Visa Program
10Approved SUV Program from Canada
12Visited to Prepare CL2 Lab. in Vancouver BC
04Established CREJUV BIO Inc. in BC Canada
09Start Fundraising for Final 10M USD
01Formulation Patent Pending